bibliographicCitation |
Jin J, Sunusi S, Lu H. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target. J Int Med Res. 2022 Jan;50(1):3000605211053156. PMID: 35048721; PMCID: PMC8796086. |